POSTER SESSION VI
Wednesday, March 21, 2012   —  1:00 PM - 4:00 PM
CC Exhibit Hall B3 & C


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...


DERMATOPATHOLOGY



Poster#Title and AuthorsItinerary
Planner
96 SSTR2A Is Highly Expressed in Metastatic Uveal Melanoma (482)
M Coronel, ME Valsecchi, T Sato, AK Witkiewicz - Thomas Jefferson University Hospital, Philadelphia, PA 		Add
97 Implications of the 2009 AJCC Melanoma Staging and Classification System for Thin Melanomas (479)
VH Chu, MT Tetzlaff, VG Prieto, C Torres-Cabala, R Bassett, MS McLemore, D Ivan, W-L Wang, JL Curry - Baylor College of Medicine, Houston, TX; MD Anderson Cancer Center, Houston, TX 		Add
98 The National Impact of the Rising Incidence of Scalp Melanoma in Central Texas (477)
C Chisholm, C Housewright, JF Greene, C Verheyden - Scott & White Memorial Hospital, Temple, TX 		Add
99 Lymphovascular Markers in Melanoma Sentinel Lymph Nodes (526)
SG Neill, GW Carlson, AJ Page, J Wang, C Cohen - Emory University School of Medicine, Atlanta, GA 		Add
100 Sentinel Lymph Node Metastases in Problematic Spitzoid Melanocytic Tumors: Not a Predictor of Malignancy (505)
T Hung, A Piris, A Lobo, MM Mihm, AJ Sober, H Tsao, KK Tanabe, LM Duncan - Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada; Massachusetts General Hospital and Harvard Medical School, Boston, MA; Hospital das Clinicas, University of Sao Paulo, Sao Paulo, Brazil; Brigham and Women´s Hospital and Harvard Medical School, Boston, Boston, MA 		Add
101 Comparison of Histopathology and Gene Expression Microarray Signatures of Spitzoid Tumors (500)
JD Hillman, RR Huang, X Li, AJ Cochran, SW Binder - David Geffen School of Medicine at UCLA, Los Angeles, CA 		Add
102 Diagnosis of Melanocytic Skin Tumors by MALDI Imaging Mass Spectrometry (MALDI IMS) (543)
A Sepehr, E Seeley, A Harris, S Tahan, R Caprioli - Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; Vanderbilt University, Nashville, TN 		Add
103 Loss of microRNA-205 Expression Is Associated with Melanoma Progression (553)
MT Tetzlaff, S Liu, A Liu, B Liegl-Atzwanger, X Xu - The University of Texas MD Anderson Cancer Center, Houston, TX; The Hospital of the University of Pennsylvania, Philadelphia, PA; The University of Graz, Graz, Austria 		Add
104 A Ratio of miR-30b/miR-205 Is Accurate in Distinguishing Spitz Nevus from Primary Cutaneous Melanoma (520)
L Margolis, J Chen, Z Nick, D Barber, H Feilotter, T Victor - Queen´s University, Kingston, ON, Canada; University of Calgary, Calgary, AB, Canada 		Add
105 Clinical Correlates of Specific BRAF and NRAS Mutations in Melanoma (552)
EE Syklawer, J Jakob, RL Bassett, JE Gershenwald, VG Prieto, JL Curry, MA Davies, AJ Lazar - University of Texas Health Science Center at Houston, Houston, TX; The University of Texas MD Anderson Cancer Center, Houston, TX 		Add
106 Immunohistochemical Staining for p-ERK: A Potential Screening Tool for BRAF Mutations in Melanoma (511)
JS Ko, SD Billings, L Durkin, WL Wang, AJ Lazar, ED Hsi - Cleveland Clinic, Cleveland, OH; MD Anderson Cancer Center, Houston, TX 		Add
107 Fluorescence In Situ Hybridization (FISH) Reliably Distinguishes Tumour Cells of Benign Melanocytic Nevi from Those of Metastatic Melanoma (549)
M Sidiropoulos, Z Hindi, A Al-Habeeb, D Ghazarian, KJ Craddock - University of Toronto, Toronto, ON, Canada; University Health Network, Toronto, ON, Canada 		Add
108 Use of Gene Expression Microarray To Discriminate Conventional Melanoma, Nevoid Melanoma and Benign Atypical Nevi (503)
RR Huang, GP Sarantopoulos, B Bernaba, XM Li, J Zhou, S Binder, AJ Cochran - Geffen-UCLA School of Medicine, Los Angeles, CA 		Add
109 Exploration of a Genotype-Phenotype Correlation in a Panel of Metastatic Human Melanoma Cell Lines (467)
A Boni, MS Ernstoff, MC Schwab, JL Fisher, LJ Tafe, GJ Tsongalis - Dartmouth Hitchcock Medical Center, Lebanon, NH 		Add
110 Expression of DICER, BIM, and PTEN in Malignant Melanoma: Role in Survival Mechanism and Adjuncts in Risk Stratification (497)
TT Ha, EM Hyjek, CR Shea, V Petronic-Rosic, T Krausz - University of Chicago, Chicago, IL 		Add
111 Nevus Density May Affect Melanoma Survival (537)
MD Reyes, KL Reyes, S Paine, R Barnhill, M Berwick - University of New Mexico, Albuquerque, NM; Hôpital Saint- Louis, Université Paris VII, Paris, France 		Add
112 Acral Nevi as Possible Precursors to Acral Melanomas? (516)
J Lai, CM Magro - University of Toronto, Toronto, ON, Canada; Weill Cornell Medical College, New York, NY 		Add
113 Diagnostic Utility and Comparative Immunohistochemical Analysis of MITF and SOX10 in Melanoma In-Situ: A Clinicopathological and Immunohistochemical Study of 50 Cases (468)
JN Buonaccorsi, S Suster, VG Prieto, JA Plaza - Medical College of Wisconsin, Milwaukee, WI; MD Anderson Cancer Center, Houston, TX 		Add
114 MITF Is the Most Effective Melanocytic Marker for Evaluation of Atypical Intraepidermal Melanocytic Proliferations (528)
GE Nybakken, M Sargen, R Abraham, X Xu - Hospital of the University of Pennsylvania, Philadelphia, PA 		Add
115 Clinico-Pathological Correlates of Vulvar Melanosis with Melanocytic Atypia (546)
I Shendrik, AN Crowson - Regional Medical Laboratory, Tulsa, OK; University of Oklahoma, Oklahoma City, OK 		Add
116 C-Kit Protein Expression in Female Lower Genital Tract Melanoma (534)
CN Prieto-Granada, N Setia, JL Garb, WH Duke, JM Henneberry - Baystate Medical Center, Springfield, MA 		Add
117 Study of the Transferrin Receptor Expression in Melanocytic Lesions: Diagnosis and Prognosis Evaluation (502)
S Houlle, P Courville, J-C Sabourin - Rouen University Hospital, Rouen, France 		Add
118 The Expression of BRCA1-Associated Protein 1 (BAP1) in Dermal Melanoma (544)
AA Shah, LB Brill, MJ Mentrikoski, C Slingluff, MR Wick, EB Stelow - University of Virginia, Charlottesville 		Add
119 Distinct Patterns of Ciliation in Divergent Classes of Melanocytic Lesions (484)
S Dabiri, ES Seeley, J Kim - Stanford, Stanford, CA 		Add
120 Diagnostic Value of Neural Progenitor Cell Markers Nestin and Sox2 in Melan-A Negative and HMB-45 Negative Melanoma (474)
P-L Chen, W-S Chen, J Li, AC Lind, D Lu - Washington University School of Medicine, Saint Louis 		Add
121 Interobserver Agreement of Assessment of Desmoplasia and Neurotropism in Melanoma (525)
R Murali, ER Riedel, KJ Busam, WA Cooper, M Garrido-Ruiz, RZ Karim, T Leecy, MP Pulitzer, RA Scolyer - Memorial Sloan-Kettering Cancer Center, New York; Royal Prince Alfred Hospital, Sydney, Australia; Melanoma Institute Australia, Sydney, Australia 		Add
122 Use of Immunohistochemistry (HMB-45,p16 and Ki-67) in the Diagnosis of Spitzoid Lesions (489)
O Erdem, D Ivan, VG Prieto - Gazi University Medical School, Ankara, Turkey; University of Texas MD Anderson Cancer Centre, Houston, TX 		Add
123 Comparison between the Conventional and Phospho-Histone H3 (PHH3) Immunohistochemistry-Assisted Mitotic Count in Different Subtypes of Melanomas (529)
VO Osipov, T Purdy, LC Giles - Labtests, Auckland, New Zealand 		Add
124 Use of Anti-PhosphohistoneH3 Immunohistochemistry To Determine Mitotic Rate in Melanoma and Its Correlation with the Lymph Node Status (464)
L Ali, C McDonald, MD Ioffreda, LE Clarke, W Porter, KF Helm - The Penn State Milton S. Hershey Medical Center, Hershey, PA; William Beaumont Hospital, Royal Oak, MI 		Add
125 Nevi with Epithelioid Cytomorphology and Architectural Disorder (508)
J Kaplan, SR Tahan - Beth Israel Deaconess Medical Center, Boston 		Add
126 Pigmented Basal Cell Carcinoma: Increased Melanin or Increased Melanocytes? (513)
JA Kozel, EM Prodanovic, MY Hurley - Saint Louis University, Saint Louis, MO 		Add
127 Basal Cell Carcinomas of the Vulva Are Unrelated to High- Risk Human Papillomavirus (488)
H Elwood, J Kim, BM Ronnett, J Taube - The Johns Hopkins Hospital, Baltimore, MD; Stanford University Hospital, Stanford, CA 		Add
128 BerEp4, Cytokeratin 17, and Cytokeratin 14 Immunohistochemical Staining Aid in Differentiatation of Basaloid Squamous Cell Carcinoma from Basal Cell Carcinoma with Squamous Features (494)
DC Gimbel, KR Linskey, L Zukerberg, LM Duncan, PM Sadow, RM Nazarian - Masachusetts General Hospital, Boston 		Add
129 Perianal Verrucous Porokeratosis, a Rare Lesion Mimicking Inflammatory and Neoplastic Conditions (561)
RM Ziegler, K Darabi, JS Roy, CS Embi, SB Peters - The Ohio State University Medical Center, Columbus, OH 		Add
130 First Complete Full-Face Allograft Transplantation. Clinicopathologic Features of Graft Rejection (554)
JJ Torres, B Ferrer, J-P Barret, J Bueno, C Romagosa, S Ramon y Cajal, P Huguet - Vall d´Hebron Universitary Hospital, Barcelona, Catalonia, Spain 		Add
131 Mass Spectrometric-Based Proteomic Analysis of Cutaneous Occlusive Vascular Diseases in Formalin-Fixed Tissues (547)
W Shon, MJ Camilleri, LA Erickson, A Dogan, TJ Flotte - Mayo Clinic, Rochester, MN 		Add